Tapewire

NYSE · USD

ENVA

Enova International, Inc.

Export transactions ↓
Tapewire entity
3836
SEC CIK
0001529864
Parsed reports
520

Last 12 months

Inside the activity.

0 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202605
Feb 202605
Mar 202600
Apr 202602
May 202605
Jun 202604
Jul 202602
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 04, 2021 Filed Mar 5, 2022 01:11 UTC
Cunningham Steven EChief Financial Officer
GrantStock Option (right to buy) with limited SAR · Derivative 11,272 $0.00 Strike: $35.75 $0.00
Disclosure

SEC source: 0000899243-22-009559 · doc4.xml · derivative · entry 2

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,299

Underlying: Common stock, par value $0.00001 per share · 11,272 shares

Expires 2028-11-04

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025.

Read SEC document
November 04, 2021 Filed Mar 5, 2022 00:46 UTC
Rahilly SeanGeneral Counsel and Secretary
GrantStock Option (right to buy) with limited SAR · Derivative 4,580 $0.00 Strike: $35.75 $0.00
Disclosure

SEC source: 0000899243-22-009517 · doc4.xml · derivative · entry 3

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,981

Underlying: Common stock, par value $0.00001 per share · 4,580 shares

Expires 2028-11-04

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F6 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025.

Read SEC document
November 01, 2021 Filed Nov 2, 2021 15:56 UTC
Chartier KirkChief Marketing Officer
SaleCommon stock, par value $0.00001 per share 8,719 $33.55 $292,519.83
Disclosure

SEC source: 0000899243-21-042323 · doc4.xml · nonDerivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,618

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Chartier's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.72 to $34.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
October 15, 2021 Filed Mar 5, 2022 00:46 UTC
Rahilly SeanGeneral Counsel and Secretary
SaleCommon stock, par value $0.00001 per share 1,430 $36.59 $52,324.70
Disclosure

SEC source: 0000899243-22-009517 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,127

F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/18/2021 adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
October 09, 2021 Filed Oct 12, 2021 21:36 UTC
Rahilly SeanGeneral Counsel and Secretary
Tax withholdingCommon stock, par value $0.00001 per share 656 $36.06 $23,655.36
Disclosure

SEC source: 0000899243-21-039893 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,557

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on October 9, 2021. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of Mr. Rahilly.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

F3 · balance_after: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on October 9, 2021. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of Mr. Rahilly.

Read SEC document
October 07, 2021 Filed Oct 12, 2021 10:05 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 20,953 $35.80 $750,023.11
Disclosure

SEC source: 0000899243-21-039779 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 476,088

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.52 to $36.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 16:09 UTC
Rahilly SeanGeneral Counsel and Secretary
SaleCommon stock, par value $0.00001 per share 4,290 $35.00 $150,150.00
Disclosure

SEC source: 0000899243-21-038159 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,213

F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/18/2021 adopted by the reporting person.

Read SEC document
September 09, 2021 Filed Sep 13, 2021 19:56 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 4,587 $32.70 $149,974.26
Disclosure

SEC source: 0000899243-21-035653 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497,041

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.19 to $32.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
August 16, 2021 Filed Aug 17, 2021 16:03 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 4,736 $31.67 $150,004.75
Disclosure

SEC source: 0000899243-21-033216 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 501,628

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
August 03, 2021 Filed Mar 5, 2022 01:08 UTC
Chartier KirkChief Strategy Officer
GrantStock Option (right to buy) with limited SAR · Derivative 9,256 $0.00 Strike: $31.98 $0.00
Disclosure

SEC source: 0000899243-22-009553 · doc4.xml · derivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,052

Underlying: Common stock, par value $0.00001 per share · 9,256 shares

Expires 2028-08-03

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025.

Read SEC document
August 03, 2021 Filed Mar 5, 2022 01:04 UTC
Fisher DavidDirector · Chief Executive Officer
GrantStock Option (right to buy) with limited SAR · Derivative 42,466 $0.00 Strike: $31.98 $0.00
Disclosure

SEC source: 0000899243-22-009545 · doc4.xml · derivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,217,948

Underlying: Common stock, par value $0.00001 per share · 42,466 shares

Expires 2028-08-03

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025.

Read SEC document
August 03, 2021 Filed Mar 5, 2022 01:11 UTC
Cunningham Steven EChief Financial Officer
GrantStock Option (right to buy) with limited SAR · Derivative 11,087 $0.00 Strike: $31.98 $0.00
Disclosure

SEC source: 0000899243-22-009559 · doc4.xml · derivative · entry 1

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,027

Underlying: Common stock, par value $0.00001 per share · 11,087 shares

Expires 2028-08-03

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025.

Read SEC document
August 03, 2021 Filed Mar 5, 2022 00:46 UTC
Rahilly SeanGeneral Counsel and Secretary
GrantStock Option (right to buy) with limited SAR · Derivative 4,504 $0.00 Strike: $31.98 $0.00
Disclosure

SEC source: 0000899243-22-009517 · doc4.xml · derivative · entry 2

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,401

Underlying: Common stock, par value $0.00001 per share · 4,504 shares

Expires 2028-08-03

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025.

Read SEC document
July 09, 2021 Filed Jul 12, 2021 20:21 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 4,445 $33.75 $150,017.42
Disclosure

SEC source: 0000899243-21-028103 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,364

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.21 to $34.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 15, 2021 Filed Jun 16, 2021 17:23 UTC
Rahilly SeanGeneral Counsel and Secretary
SaleCommon stock, par value $0.00001 per share 1,430 $35.01 $50,064.30
Disclosure

SEC source: 0000899243-21-024099 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,503

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/21/2021 adopted by the reporting person.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 16:16 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 8,444 $35.52 $299,945.23
Disclosure

SEC source: 0000899243-21-024090 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 510,809

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
May 17, 2021 Filed May 18, 2021 16:21 UTC
Rahilly SeanGeneral Counsel and Secretary
SaleCommon stock, par value $0.00001 per share 1,430 $36.51 $52,209.30
Disclosure

SEC source: 0000899243-21-019737 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,933

F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/21/2021 adopted by the reporting person.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:53 UTC GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019234 · doc4.xml · nonDerivative · entry 1

CARNAHAN ELLEN · CIK 0001037175 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,170

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:56 UTC GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019237 · doc4.xml · nonDerivative · entry 1

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,955

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:44 UTC
TEBBE MARKDirector
GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019221 · doc4.xml · nonDerivative · entry 1

TEBBE MARK · CIK 0001131785 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,495

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:50 UTC
McGowan MarkDirector
GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019231 · doc4.xml · nonDerivative · entry 1

McGowan Mark · CIK 0001482192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,487

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:52 UTC GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019233 · doc4.xml · nonDerivative · entry 1

KAPLAN GREGG A. · CIK 0001461299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,355

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:57 UTC GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019239 · doc4.xml · nonDerivative · entry 1

FEEHAN DANIEL R · CIK 0001188234 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,142

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:45 UTC GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019223 · doc4.xml · nonDerivative · entry 1

RICE LINDA JOHNSON · CIK 0001188735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,445

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 11, 2021 Filed May 12, 2021 18:49 UTC
Gray James ADirector
GrantCommon stock, par value $0.00001 per share 3,966 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019228 · doc4.xml · nonDerivative · entry 1

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,495

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 11, 2022, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 10, 2021 Filed May 12, 2022 22:12 UTC GrantCommon stock, par value $0.00001 per share 4,180 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-017822 · doc4.xml · nonDerivative · entry 1

GOODYEAR WILLIAM M · CIK 0001115909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,175

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 10, 2023, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 10, 2021 Filed May 12, 2022 22:11 UTC GrantCommon stock, par value $0.00001 per share 4,180 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-017821 · doc4.xml · nonDerivative · entry 1

FEEHAN DANIEL R · CIK 0001188234 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,322

F1 · shares: Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 10, 2023, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date.

Read SEC document
May 03, 2021 Filed May 5, 2021 15:38 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 9,907 $35.33 $350,034.12
Disclosure

SEC source: 0000899243-21-018296 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,253

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.69 to $35.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
April 28, 2021 Filed Apr 29, 2021 16:54 UTC
Rahilly SeanGeneral Counsel and Secretary
SaleCommon stock, par value $0.00001 per share 1,430 $35.00 $50,050.00
Disclosure

SEC source: 0000899243-21-017345 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,363

F1 · shares: The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
April 08, 2021 Filed Apr 12, 2021 19:47 UTC
Chartier KirkChief Marketing Officer
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative 35,289 $21.34 Strike: $34.25 $753,067.26
Disclosure

SEC source: 0000899243-21-015526 · doc4.xml · derivative · entry 3

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,796

Underlying: Common stock, par value $0.00001 per share · 35,289 shares

Expires 2026-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan, dated March 9, 2021, adopted by the reporting person.

F6 · derivative.exercise_date: The options vested or will vest in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 12, 2020, February 12, 2021 and February 12, 2022.

Read SEC document
April 08, 2021 Filed Apr 12, 2021 19:47 UTC
Chartier KirkChief Marketing Officer
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative 69,275 $23.04 Strike: $34.25 $1,596,096.00
Disclosure

SEC source: 0000899243-21-015526 · doc4.xml · derivative · entry 2

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,085

Underlying: Common stock, par value $0.00001 per share · 69,275 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan, dated March 9, 2021, adopted by the reporting person.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

Read SEC document
April 08, 2021 Filed Apr 12, 2021 19:47 UTC
Chartier KirkChief Marketing Officer
SaleCommon Stock, par value $0.00001 3,623 $34.02 $123,265.33
Disclosure

SEC source: 0000899243-21-015526 · doc4.xml · nonDerivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,337

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $34.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan, dated March 9, 2021, adopted by the reporting person.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 21:18 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 27,951 $35.78 $999,947.03
Disclosure

SEC source: 0000899243-21-015117 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 529,160

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 15, 2021 Filed Mar 16, 2021 20:05 UTC
Fisher DavidDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative 98,185 $23.04 Strike: $39.63 $2,262,182.40
Disclosure

SEC source: 0000899243-21-011930 · doc4.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,175,482

Underlying: Common stock, par value $0.00001 per share · 98,185 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

Read SEC document
March 11, 2021 Filed Mar 15, 2021 20:42 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 5,000 $39.70 $198,500.00
Disclosure

SEC source: 0000899243-21-011587 · doc4.xml · nonDerivative · entry 2

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 10,000

Read SEC document
March 11, 2021 Filed Mar 15, 2021 20:42 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 5,000 $39.75 $198,750.00
Disclosure

SEC source: 0000899243-21-011587 · doc4.xml · nonDerivative · entry 1

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 15,000

Read SEC document
March 09, 2021 Filed Mar 10, 2021 20:29 UTC SaleCommon stock, par value $0.00001 per share 8,703 $36.50 $317,659.50
Disclosure

SEC source: 0000899243-21-010962 · doc4.xml · nonDerivative · entry 1

KAPLAN GREGG A. · CIK 0001461299 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,389

Read SEC document
March 05, 2021 Filed Mar 5, 2021 22:38 UTC
Rahilly SeanGeneral Counsel and Secretary
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative 8,799 $23.04 Strike: $34.39 $202,728.96
Disclosure

SEC source: 0000899243-21-010164 · doc4.xml · derivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,897

Underlying: Common stock, par value $0.00001 per share · 8,799 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.14 to $34.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

Read SEC document
March 04, 2021 Filed Mar 5, 2022 01:04 UTC
Fisher DavidDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative 70,000 $23.04 Strike: $32.95 $1,612,800.00
Disclosure

SEC source: 0000899243-22-009545 · doc4.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,273,667

Underlying: Common stock, par value $0.00001 per share · 70,000 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.56 to $33.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

Read SEC document
March 03, 2021 Filed Mar 4, 2021 22:05 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 2,854 $32.47 $92,669.38
Disclosure

SEC source: 0000899243-21-009861 · doc4.xml · nonDerivative · entry 2

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 20,000

Read SEC document
March 03, 2021 Filed Mar 4, 2021 22:05 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 2,146 $32.45 $69,637.70
Disclosure

SEC source: 0000899243-21-009861 · doc4.xml · nonDerivative · entry 1

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 22,854

Read SEC document
March 02, 2021 Filed Mar 3, 2021 23:24 UTC
Fisher DavidDirector · Chief Executive Officer
SaleCommon Stock, par value $0.00001 32,476 $30.79 $999,936.04
Disclosure

SEC source: 0000899243-21-009489 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 557,111

F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.54 to $31.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 20:37 UTC
Chartier KirkChief Marketing Officer
GrantCommon stock, par value $0.00001 per share 24,920 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-008936 · doc4.xml · nonDerivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,960

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 20:38 UTC
Fisher DavidDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) with limited SAR · Derivative 72,672 $23.04 Strike: $31.72 $1,674,362.88
Disclosure

SEC source: 0000899243-21-008939 · doc4.xml · derivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,343,667

Underlying: Common stock, par value $0.00001 per share · 72,672 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.50 to $32.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 20:38 UTC
Fisher DavidDirector · Chief Executive Officer
GrantCommon stock, par value $0.00001 per share 114,334 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-008939 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 589,587

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 20:42 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 2,000 $32.00 $64,000.00
Disclosure

SEC source: 0000899243-21-008942 · doc4.xml · nonDerivative · entry 1

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 25,000

Read SEC document
March 01, 2021 Filed Mar 2, 2021 20:39 UTC
Cunningham Steven EChief Financial Officer
GrantCommon stock, par value $0.00001 per share 29,850 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-008940 · doc4.xml · nonDerivative · entry 1

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,549

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 20:35 UTC
Rahilly SeanGeneral Counsel and Secretary
GrantCommon stock, par value $0.00001 per share 12,128 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-008935 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,793

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 9, 2022, February 9, 2023, February 9, 2024 and February 9, 2025.

Read SEC document
February 19, 2021 Filed Feb 22, 2021 20:55 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 300 $29.74 $8,922.00
Disclosure

SEC source: 0000899243-21-007562 · doc4.xml · nonDerivative · entry 3

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 27,000

Read SEC document
February 19, 2021 Filed Feb 22, 2021 20:55 UTC
Gray James ADirector
SaleCommon stock, par value $0.00001 per share 263 $29.73 $7,818.99
Disclosure

SEC source: 0000899243-21-007562 · doc4.xml · nonDerivative · entry 2

Gray James A · CIK 0001315492 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · JG 2002 Delta Trust

Disclosed balance after: 27,300

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.